Jacqueline Phillips is a Senior Director in the Child Health Innovation Leadership Department (CHILD) at Johnson & Johnson where her primary responsibilities are support of pediatric product development. She is a board-certified pediatrician and a fellow member of both the American Academy of Pediatrics (AAP) and the Society of Critical Care Medicine (SCCM). Within Johnson & Johnson Innovation (JJI), she is a JPAL as well as a reviewer and judge for Quickfire Challenge competitions and a consultant to the JLABS@DC incubator.  
She earned her medical degree from New York Medical College, completed a residency in pediatrics at Albert Einstein College of Medicine and a fellowship in pediatric critical care at Children’s National Medical Center. Jacqueline also received her Master’s in Business Administration from Rutgers Business School.

Lee Ann Savio Beers, MD, is the president-elect of the American Academy of Pediatrics, a Professor of
Pediatrics and the Medical Director for Community Health and Advocacy at Children’s National Hospital. She is the Founding Director of the DC Mental Health Access in Pediatrics program and CoDirector of the Early Childhood Innovation Network.

She also oversees the Child Health Advocacy Institute’s Community Mental Health CORE, a public-private coalition that serves as a catalyst to elevate the standard of mental health care for every young person in Washington DC. Dr Beers will begin her one-year term as AAP president on Jan. 1, 2021. She earned her Medical Degree from Emory University School of Medicine and completed a pediatric
residency at the Naval Medical Center in Portsmouth VA.

 Holli Hamilton is an infectious disease physician who also trained in preventive medicine, public health medicine and clinical microbiology. She has a broad clinical experience having worked in public health departments, prisons, jails, universities, international sites and industry. She retired from the federal government in 2019.

She worked at FDA where she acquired a knowledge of regulatory science after working in the product safety area, a review division and as medical officer in the Pregnancy and Labeling Team. She also worked at NIH in three institutes where she gained broad experience in study design, safety oversight, medical monitoring, clinical operations and developing programs to meet scientific goals. She returned to government to join the COVID-19 effort last May.

.Caleb Hernandez is a board-certified emergency medicine physician, inventor, and the CEO and founder of Certa Dose Inc. Certa Dose is the result of Dr. Hernandez’s passion for bringing patient safety and high reliability to the practice of medicine.

In developing Certa Dose, he’s been able to create a range of solutions to help reduce dosage errors and adverse drug events. He is listed as an inventor on multiple patents. Several peer-reviewed journals have published his work on this subject, and he is a regular speaker at emergency medicine conferences. He has worked with major pharmaceutical companies and government agencies to develop large scale solutions that consider the special requirements of vulnerable populations such as infants and children. In his spare time, Dr. Hernandez enjoys writing music.

Gary Noel, MD, is Chief Medical Officer at The Institute for Advanced Clinical Trials (I-ACT) for Children. Dr. Noel is a pediatrician, child advocate, specialist in Infectious Diseases and Immunology and a seasoned expert in drug development, having spent more than 30 years in leadership roles in
the biopharmaceutical industry and academia.

He will be joined I-ACT for Children on after retiring from Johnson & Johnson, where he most recently served as a member of the Child Health Innovation Leadership Department in the Office of the Chief Medical Officer and as chair of its Pediatric Expert Panel.